OTC · Biotechnology

Herantis Pharma Oyj (HRPMF) Stock

$3.51 +0.00% OTC: HRPMF Healthcare

Herantis Pharma Oyj, a biotechnology enterprise, specializes in creating disease-modifying therapies for Parkinson's disease (PD) that harness Cerebral Dopamine Neurotrophic Factor (CDNF). Central to its developmental efforts is HER-096, a sophisticated, compact, synthetic chemical peptidomimetic originating from the active parent molecule.

Valuation

MetricValue
Price$3.51
Market Cap$59.47M
P/E Ratio-6.09
P/B Ratio-23.48
P/S Ratio0.00
EPS (TTM)$-0.24
52-Week High$3.51
52-Week Low$3.51
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE—
ROA-248.13%
ROCE-364.24%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-2.04
Current Ratio2.93

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-8.0M$-9.0M$-8.0M$0$-5.0M
Net Profit$-9.0M$-24.0M$-9.0M$0$-5.0M
EPS$-1.18$-2.20$-0.64$0.02$-0.24
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$16.0M$7.0M$6.0M$7.0M$3.0M
Total Liabilities$9.0M$6.0M$6.0M$2.0M$3.0M
Cash$12.0M$6.0M$5.0M$6.0M$1.0M
Borrowings$7.0M$5.0M$5.0M$0$0

Latest News

Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm GlobeNewswire · Jul 23, 2026 EasyJet says profits nosedive on Mideast war AFP · Jul 23, 2026 Acrab Unveils GΞLIX 1 SoC and Agent Box, Bringing State-of-the-Art AI to the Edge PR Newswire · Jul 23, 2026 Houthis say they attacked 2 Saudi oil tankers in the Red Sea as US carries out 12th night of strikes Associated Press · Jul 23, 2026 Taylor Morrison Home Shareholders Approve Berkshire Hathaway Merger MarketBeat · Jul 23, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-9.0M$-10.0M$-9.0M$-5.0M$-7.0M
Investing Cash Flow$0$0$0$1.0M$0
Financing Cash Flow$0$4.0M$0$4.0M$2.0M
Net Cash Flow$6.0M$-6.0M$-1.0M$0$-5.0M
Free Cash Flow$-9.0M$-10.0M$-9.0M$-5.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.49
EV / EBITDA-7.23
FCF Yield-13.99%
Quick Ratio2.93
Interest Coverage-17.97
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSTGBiostage, Inc. $4.03 +0.75% -9.83 $57.82M 0.00%
DMTTFSmall Pharma Inc. $0.11 -9.69% -2.20 $37.51M 0.00%
EEOIFElegance Optical International Holdings Limited $0.07 +0.00% 20.33 $63.38M 0.00%
GDNSFGoodness Growth Holdings, Inc. $0.45 — -4.52 $61.05M 0.00%
KDEVFKarolinska Development AB (publ) $0.26 +0.00% -0.34 $68.85M 0.00%

About Herantis Pharma Oyj

Herantis Pharma Oyj, a biotechnology enterprise, specializes in creating disease-modifying therapies for Parkinson's disease (PD) that harness Cerebral Dopamine Neurotrophic Factor (CDNF). Central to its developmental efforts is HER-096, a sophisticated, compact, synthetic chemical peptidomimetic originating from the active parent molecule. This preclinical xCDNF candidate is currently being investigated for its therapeutic promise in PD and other neurodegenerative conditions. Additionally, the firm is advancing recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is presently undergoing Phase I clinical evaluation in individuals afflicted with Parkinson's. Founded in 2008, Herantis Pharma Oyj maintains its corporate headquarters in Espoo, Finland.

Herantis Pharma Oyj is headquartered in FI.

Herantis Pharma Oyj (HRPMF) stock trades at $3.51 with a market capitalization of $59.47M. The stock is valued at a price-to-earnings (P/E) ratio of -6.09, price-to-book of -23.48, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.51 and $3.51, and currently trades at its 52-week high.

On profitability, Herantis Pharma Oyj generates return on capital employed of -364.24%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.herantis.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides